Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 58 Ovarian Neoplasms 7 Neoplasm Metastasis 7 Endometrial Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Neoplasms 4 Hereditary Sensory and Autonomic Neuropathies 4 Advanced Breast Cancer 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Colorectal Neoplasms 3 Neoplasms by Site 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Carcinoma, Ovarian Epithelial 2 Breast Diseases 2 Advanced Solid Tumors 2 Advanced Solid Tumor 2 Unilateral Breast Neoplasms 1 Spinocerebellar Degenerations 1 Salivary Gland Neoplasms 1 Recurrence 1 Prostatic Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Locoregional Recurrence 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 HR+/HER2- Breast Cancer 1 HR+ Breast Cancer 1

Interventions

palbociclib 1 exemestane 1 elacestrant 1 Tamoxifen 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × ER+ Breast Cancer × Fulvestrant × Clear all

NCT04985266 2024-12-05

TRAK-ER

Royal Marsden NHS Foundation Trust

Phase 2 Recruiting

ER+ Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡